Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang CapitalGlobeNewsWire • 09/19/24
Singular Genomics to Report Second Quarter 2024 Financial Results on August 13, 2024GlobeNewsWire • 07/30/24
Singular Genomics Regains Compliance with Nasdaq Minimum Bid Price RequirementGlobeNewsWire • 07/15/24
Singular Genomics to Present at the Goldman Sachs Global Healthcare ConferenceGlobeNewsWire • 05/29/24
Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial ResultsGlobeNewsWire • 05/14/24
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewsWire • 03/18/24
Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024GlobeNewsWire • 03/04/24
Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing PlatformGlobeNewsWire • 02/05/24
Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic AnalysisGlobeNewsWire • 02/05/24
Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 RevenueGlobeNewsWire • 01/07/24
Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial ResultsGlobeNewsWire • 11/14/23
Singular Genomics to Report Third Quarter 2023 Financial Results on November 14, 2023GlobeNewsWire • 10/24/23
Singular Genomics to Present at the Gilmartin Group Emerging Growth Company ShowcaseGlobeNewsWire • 09/08/23
Top 5 Health Care Stocks That May Explode In Q3 - BioVie (NASDAQ:BIVI), Galera Therapeutics (NASDAQ:GRTX)Benzinga • 09/06/23